Clinical evaluation of beta 2-microglobulin, muramidase, and alanine aminopeptidase as markers of gentamicin nephrotoxicity.
D000626:Aminopeptidases / Q000652:urine*; D018826:CD13 Antigens; D005839:Gentamicins / Q000633:toxicity*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D009113:Muramidase / Q000652:urine*; D001613:beta 2-Microglobulin / Q000652:urine*
D005839:Gentamicins; D001613:beta 2-Microglobulin; D009113:Muramidase; D000626:Aminopeptidases; D018826:CD13 Antigens